c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target

BACKGROUND: c-Met is widely known as a poor prognostic factor in various human malignancies. Previous studies have suggested the involvement of c-Met and/or its ligand, hepatocyte growth factor (HGF), in esophageal squamous cell carcinoma (ESCC), but the correlation between c-Met status and clinical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Ozawa, Yohei, Nakamura, Yasuhiro, Fujishima, Fumiyoshi, Felizola, Saulo JA, Takeda, Kenichiro, Okamoto, Hiroshi, Ito, Ken, Ishida, Hirotaka, Konno, Takuro, Kamei, Takashi, Miyata, Go, Ohuchi, Noriaki, Sasano, Hironobu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453225/
https://ncbi.nlm.nih.gov/pubmed/26036285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1450-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars